TrialJournal of the Chinese Medical Association : JCMA2022
Low-dose ferrous bisglycinate chelate supplementation in chronic kidney disease and hemodialysis patients.
Cheng-Yi Hsu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it